Clinical Trial Update: A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

View source ↗

Summary

A real-world study investigating Faricimab (Vabysmo) for neovascular age-related macular degeneration and diabetic macular edema is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• VABYSMO (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Status: RECRUITING